Stockreport

LifeMD: Selling WorkSimpli Could Be A Catalyst [Seeking Alpha]

LifeMD, Inc.  (LFMD) 
PDF Summary LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite managemen [Read more]